Literature DB >> 25154344

The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns.

Atul Deodhar1, John D Reveille, Filip van den Bosch, Jürgen Braun, Ruben Burgos-Vargas, Liron Caplan, Daniel O Clegg, Robert A Colbert, Lianne S Gensler, Désirée van der Heijde, Irene E van der Horst-Bruinsma, Robert D Inman, Walter P Maksymowych, Philip J Mease, Siba Raychaudhuri, Andreas Reimold, Martin Rudwaleit, Joachim Sieper, Michael H Weisman, Robert B M Landewé.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25154344     DOI： 10.1002/art.38776

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  30 in total

Review 1.  Imaging in Spondyloarthritis: Controversies in Recognition of Early Disease.

Authors:  Ulrich Weber; Anne Grethe Jurik; Robert G W Lambert; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2016-09       Impact factor: 4.592

Review 2.  Axial spondyloarthritis: concept, construct, classification and implications for therapy.

Authors:  Philip C Robinson; Sjef van der Linden; Muhammad A Khan; William J Taylor
Journal:  Nat Rev Rheumatol       Date:  2020-12-23       Impact factor: 20.543

Review 3.  Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.

Authors:  Nurullah Akkoc; Gercek Can; Salvatore D'Angelo; Angela Padula; Ignazio Olivieri
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

Review 4.  New evidence on the management of spondyloarthritis.

Authors:  Joachim Sieper; Denis Poddubnyy
Journal:  Nat Rev Rheumatol       Date:  2016-04-07       Impact factor: 20.543

Review 5.  Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria.

Authors:  Fabian Proft; Denis Poddubnyy
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-05-17       Impact factor: 5.346

Review 6.  Looking into the new ASAS classification criteria for axial spondyloarthritis through the other side of the glass.

Authors:  Nurullah Akkoc; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

Review 7.  Tumor necrosis factor-α (TNFα) inhibitors in the treatment of nonradiographic axial spondyloarthritis: current evidence and place in therapy.

Authors:  Valeria Rios Rodriguez; Denis Poddubnyy
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-05-09       Impact factor: 5.346

Review 8.  Axial spondyloarthritis classification criteria: the debate continues.

Authors:  Maureen Dubreuil; Atul A Deodhar
Journal:  Curr Opin Rheumatol       Date:  2017-07       Impact factor: 5.006

Review 9.  The ASAS Criteria for Axial Spondyloarthritis: Strengths, Weaknesses, and Proposals for a Way Forward.

Authors:  Sjef van der Linden; Nurullah Akkoc; Matthew A Brown; Philip C Robinson; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

Review 10.  ASAS classification criteria for axial spondyloarthritis: time to modify.

Authors:  Nurullah Akkoc; Muhammad A Khan
Journal:  Clin Rheumatol       Date:  2016-04-19       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.